Related Articles
A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells
Circulating and tumor‑infiltrating myeloid‑derived suppressor cells in cervical carcinoma patients
T‑regulatory cells from patients with rheumatoid arthritis retain suppressor functions <em>in vitro</em>
Anticancer immune reactivity and long‑term survival after treatment of metastatic ovarian cancer with dendritic cells